PLEASE NOTE: Clinical trials have indicated that Retatrutide may lead to greater average weight loss than tirzepatide, another dual-agonist medication, although retatrutide is still investigational and not yet FDA-approved
The medication works independently of meal timing
H., Fink, M., Knapp, R., Petrides, G., Husain, M., Rummans, T., Malur, C
NAD Injections vs B12 Some patients compare NAD injections and B12 when they notice less energy, focus, or motivation
this should be managed by a healthcare professional
5.3 Disease-specific metabolic phenotypes A clinically useful review must move beyond the idea that there is one metabolic program for all myocardial hypertrophy